May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...
May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new ...
May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally ...
May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
May 7, 2024 — RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology ...
May 7, 2024 — HonorHealth Research Institute’s David G. Rizik, M.D., narrates and is a co-producer of a documentary ...
May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...
May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...
May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 6, 2024 — Teleflex Incorporate, a leading global provider of medical technologies, today announced that the Wattson ...
May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...
Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...
May 10, 2024
